Literature DB >> 12467523

Cellular and cytokine immunoregulation in patients with chronic obstructive pulmonary disease and bronchial asthma.

Wanda Stankiewicz1, Marek P Dabrowski, Andrzej Chcialowski, Tadeusz Plusa.   

Abstract

BACKGROUND: Different forms of chronic airway inflammation may involve diverse pathogenic elements. In general, deficient defence response is a feature of chronic obstructive pulmonary disease (COPD), whereas distorted immunoregulatory mechanisms lead to development of asthmatic symptoms. In addition to diverse effector mechanisms, the cellular and humoral elements participating in the development of immune response may appear to be different in COPD and bronchial asthma (BA) patients. AIMS: To evaluate the immunoregulatory properties of T cells and monocytes in cultures of peripheral blood mononuclear cells (PBMC) and to determine the chosen cytokine profiles in COPD and BA patients.
METHODS: The microcultures of PBMC from COPD and BA patients were assessed for the T-cell response to mitogens, saturation of interleukin (IL)-2 receptors, T-cell suppressive activity and monokine influence on lymphocyte proliferation. Concomitantly, the cytokine (IL-1beta, interleukin-1 receptor antagonist, tumour necrosis factor-alpha, IL-4, IL-6, IL-8) concentrations were determined in the serum, the broncho-alveolar lavage fluid and in the culture supernatants.
RESULTS: The T-lymphocyte reactions (response to phytohaemagglutinin, IL-2 receptor saturation, suppressive activity) were lower in BA patients than in COPD patients. Reversely, the immunogenic activity of monocytes (IL-1beta versus IL-1ra production) was higher in BA patients than in COPD patients. The highest values of cytokine concentrations were found in the culture supernatants. The concentrations of tumour necrosis factor-alpha, IL-4, IL-6 and IL-8 were significantly higher and the concentration of IL-1ra was lower in BA patients than in COPD patients.
CONCLUSION: The assessments of cellular immunoregulatory properties and cytokine profiles in the cultures of blood mononuclear cells may prove helpful for diagnostic and therapeutic discrimination between BA and COPD patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467523      PMCID: PMC1781676          DOI: 10.1080/09629350210000015719

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  17 in total

Review 1.  The role of allergy in the development of asthma.

Authors:  P G Holt; C Macaubas; P A Stumbles; P D Sly
Journal:  Nature       Date:  1999-11-25       Impact factor: 49.962

Review 2.  Asthma.

Authors:  W W Busse; R F Lemanske
Journal:  N Engl J Med       Date:  2001-02-01       Impact factor: 91.245

Review 3.  Interleukin-5, eosinophils, and disease.

Authors:  C J Sanderson
Journal:  Blood       Date:  1992-06-15       Impact factor: 22.113

4.  Immunologic and clinical evaluation of multiple sclerosis patients treated with corticosteroids and/or calf thymic hormones.

Authors:  M P Dabrowski; B K Dabrowska-Bernstein; A Stasiak; K Gajkowski; S Korniluk
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

5.  Association of asthma with serum IgE levels and skin-test reactivity to allergens.

Authors:  B Burrows; F D Martinez; M Halonen; R A Barbee; M G Cline
Journal:  N Engl J Med       Date:  1989-02-02       Impact factor: 91.245

6.  Proinflammatory cytokines in acute asthma.

Authors:  P H Brown; G K Crompton; A P Greening
Journal:  Lancet       Date:  1991-09-07       Impact factor: 79.321

Review 7.  The role of interleukin-1 in disease.

Authors:  C A Dinarello; S M Wolff
Journal:  N Engl J Med       Date:  1993-01-14       Impact factor: 91.245

8.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.

Authors:  D S Robinson; Q Hamid; S Ying; A Tsicopoulos; J Barkans; A M Bentley; C Corrigan; S R Durham; A B Kay
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

9.  Interleukin-13: central mediator of allergic asthma.

Authors:  M Wills-Karp; J Luyimbazi; X Xu; B Schofield; T Y Neben; C L Karp; D D Donaldson
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

10.  Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma.

Authors:  M T O'Hollaren; J W Yunginger; K P Offord; M J Somers; E J O'Connell; D J Ballard; M I Sachs
Journal:  N Engl J Med       Date:  1991-02-07       Impact factor: 91.245

View more
  15 in total

1.  Grape seed proanthocyanidin extract inhibits interleukin-17-induced interleukin-6 production via MAPK pathway in human pulmonary epithelial cells.

Authors:  Hyeongseok Kim; Jin Young Kim; Hong Suk Song; Keon Uk Park; Kyo-Chul Mun; Eunyoung Ha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-04-12       Impact factor: 3.000

2.  IL-6 is required for airway mucus production induced by inhaled fungal allergens.

Authors:  Wendy A Neveu; Jenna B Allard; Oliver Dienz; Matthew J Wargo; Gennaro Ciliberto; Laurie A Whittaker; Mercedes Rincon
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

3.  Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function.

Authors:  Wendy A Neveu; Jenna L Allard; Danielle M Raymond; Lorraine M Bourassa; Stephanie M Burns; Janice Y Bunn; Charles G Irvin; David A Kaminsky; Mercedes Rincon
Journal:  Respir Res       Date:  2010-03-08

4.  Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome.

Authors:  Serkan Nural; Ersin Günay; Bilal Halici; Sefa Celik; Mehmet Ünlü
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

5.  Bioinformatic analysis of microRNA and mRNA Regulation in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease.

Authors:  Xiaomin Dang; Xiaoyan Qu; Weijia Wang; Chongbing Liao; Ying Li; Xiaojin Zhang; Dan Xu; Carolyn J Baglole; Dong Shang; Ying Chang
Journal:  Respir Res       Date:  2017-01-05

6.  Histone deacetylase inhibitors up-regulate LL-37 expression independent of toll-like receptor mediated signalling in airway epithelial cells.

Authors:  Quan Liu; Juan Liu; Kristina Irene Lisolette Roschmann; Danielle van Egmond; Korneliusz Golebski; Wytske Johanna Fokkens; Dehui Wang; Cornelis Maria van Drunen
Journal:  J Inflamm (Lond)       Date:  2013-04-11       Impact factor: 4.981

Review 7.  Airway disease: similarities and differences between asthma, COPD and bronchiectasis.

Authors:  Rodrigo Athanazio
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

8.  Hypoxia exerts dualistic effects on inflammatory and proliferative responses of healthy and asthmatic primary human bronchial smooth muscle cells.

Authors:  Laura Keglowich; Melissa Baraket; Michael Tamm; Peter Borger
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

9.  Scheimpflug Imaging Parameters Associated with Tear Mediators and Bronchial Asthma in Keratoconus.

Authors:  Dorottya Pásztor; Bence Lajos Kolozsvári; Adrienne Csutak; András Berta; Ziad Hassan; Beáta Andrea Kettesy; Péter Gogolák; Mariann Fodor
Journal:  J Ophthalmol       Date:  2016-01-12       Impact factor: 1.909

10.  In Vitro and In Vivo Anti-Allergic and Anti-Inflammatory Effects of eBV, a Newly Developed Derivative of Bee Venom, through Modulation of IRF3 Signaling Pathway in a Carrageenan-Induced Edema Model.

Authors:  Hwa-Jin Chung; Jinho Lee; Joon-Shik Shin; Me-Riong Kim; Wonil Koh; Min-Jeong Kim; Jae-Woong Lee; Eun Jee Kim; In-Hee Lee; Won Kyung Kim; Yoon Jae Lee; Sang Kook Lee; In-Hyuk Ha
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.